Created at Source Raw Value Validated value
Feb. 1, 2023, 4 p.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "Participants 18-25 y.o.", "treatment_id": 513, "treatment_name": "Finlay-fr-1a anti-sars-cov-2 vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Participants 26-80 y.o.", "treatment_id": 513, "treatment_name": "Finlay-fr-1a anti-sars-cov-2 vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]

Jan. 31, 2023, 4 p.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Protein subunit vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute.", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Protein subunit vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute.", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

Jan. 20, 2023, 8 a.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Conjugate vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute.", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Conjugate vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute.", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "18-25 y", "treatment_id": 513, "treatment_name": "Finlay-fr-1a anti-sars-cov-2 vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "26-80 y", "treatment_id": 513, "treatment_name": "Finlay-fr-1a anti-sars-cov-2 vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]